(Q44902406)

7 December 2017

0 references

Strategies for preventing influenza: future perspectives in influenza vaccine technology (English)

1 reference

7 December 2017

1 reference

Gian Vincenzo Zuccotti

series ordinal

1

1 reference

7 December 2017

2

1 reference

7 December 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

Expert Opinion on Biological Therapy

7 December 2017

published in

1 reference

7 December 2017

volume

11

1 reference

7 December 2017

issue

1

1 reference

7 December 2017

page(s)

1-4

1 reference

Safety and efficacy of live attenuated influenza vaccine in children 2-7 years of age.

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Development of cell culture (MDCK) live cold-adapted (CA) attenuated influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Humoral and cell-mediated immunity to vero cell-derived influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

New pre-pandemic influenza vaccines: an egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

A novel dry powder influenza vaccine and intranasal delivery technology: induction of systemic and mucosal immune responses in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Pulmonary delivery of an inulin-stabilized influenza subunit vaccine prepared by spray-freeze drying induces systemic, mucosal humoral as well as cell-mediated immune responses in BALB/c mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Epidermal powder immunization: cellular and molecular mechanisms for enhancing vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Improved influenza vaccination in the skin using vaccine coated microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Influenza virus-like particles coated onto microneedles can elicit stimulatory effects on Langerhans cells in human skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Mucosal delivery of inactivated influenza vaccine induces B-cell-dependent heterosubtypic cross-protection against lethal influenza A H5N1 virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

Eye mucosa: an efficient vaccine delivery route for inducing protective immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2010.539047

10.1517/14712598.2010.539047

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference